OUR PRODUCTS

MOBILE APPS

GENERAL INFO

ACXP

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Acurx Pharmaceuticals (ACXP) Earnings Date & Reports

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ACXP is expected to report earnings to fall 92.06% to -15 cents per share on November 18

Acurx Pharmaceuticals ACXP Stock Earnings Reports

Q3'25

Est.

$-0.15

Q2'25

Missed

by $1.71

Q1'25

Beat

by $0.27

Q4'24

Beat

by $0.02

Q3'24

Missed

by $0.02

The last earnings report on August 12 showed earnings per share of -188 cents, missing the estimate of -18 cents. With 17.54K shares outstanding, the current market capitalization sits at 7.48M.

View a ticker or compare two or three

Compare

ACXP

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ACXP
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ACXP showed earnings on August 12, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

259 Liberty Avenue

Phone

+1 917 533-1469

Employees

Web

https://www.acurxpharma.com